These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 8346712

  • 1. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
    Bocci V.
    J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
    [Abstract] [Full Text] [Related]

  • 2. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe?
    Gabius HJ, Gabius S, Joshi SS, Koch B, Schroeder M, Manzke WM, Westerhausen M.
    Planta Med; 1994 Feb; 60(1):2-7. PubMed ID: 8134410
    [Abstract] [Full Text] [Related]

  • 3. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
    Franz H.
    Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
    [No Abstract] [Full Text] [Related]

  • 4. [Lectin-related use of mistletoe: an experimental form of treatment with preclinically demonstrated potential risks].
    Gabius S, Gabius HJ.
    Dtsch Med Wochenschr; 2002 Mar 01; 127(9):457-9. PubMed ID: 11870561
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
    Zarković N, Kalisnik T, Loncarić I, Borović S, Mang S, Kissel D, Konitzer M, Jurin M, Grainza S.
    Cancer Biother Radiopharm; 1998 Apr 01; 13(2):121-31. PubMed ID: 10850348
    [Abstract] [Full Text] [Related]

  • 6. [Value of mistletoe lectin standardized mistletoe extract for evaluating antitumor properties].
    Mengs U, Witthohn K, Schwarz T, Lentzen H.
    Wien Med Wochenschr; 1999 Apr 01; 149(8-10):262-4. PubMed ID: 10483695
    [Abstract] [Full Text] [Related]

  • 7. Further refinement of the description of the ligand-binding characteristics for the galactoside-binding mistletoe lectin, a plant agglutinin with immunomodulatory potency.
    Galanina OE, Kaltner H, Khraltsova LS, Bovin NV, Gabius HJ.
    J Mol Recognit; 1997 Apr 01; 10(3):139-47. PubMed ID: 9408830
    [Abstract] [Full Text] [Related]

  • 8. A natural immunity-activating plant lectin, Viscum album agglutinin-I, induces apoptosis in human lymphocytes, monocytes, monocytic THP-1 cells and murine thymocytes.
    Hostanska K, Hajto T, Weber K, Fischer J, Lentzen H, Sütterlin B, Saller R.
    Nat Immun; 1997 Apr 01; 15(6):295-311. PubMed ID: 9523281
    [Abstract] [Full Text] [Related]

  • 9. Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research.
    Mengs U, Göthel D, Leng-Peschlow E.
    Anticancer Res; 2002 Apr 01; 22(3):1399-407. PubMed ID: 12168816
    [Abstract] [Full Text] [Related]

  • 10. Mistletoe extract-induced effects on immunocompetent cells: in vitro studies.
    Stein GM, Berg PA.
    Anticancer Drugs; 1997 Apr 01; 8 Suppl 1():S39-42. PubMed ID: 9179366
    [Abstract] [Full Text] [Related]

  • 11. Complete amino acid sequence of the B chain of mistletoe lectin I.
    Soler MH, Stoeva S, Voelter W.
    Biochem Biophys Res Commun; 1998 May 29; 246(3):596-601. PubMed ID: 9618256
    [Abstract] [Full Text] [Related]

  • 12. Evaluating unconventional therapies.
    Hajto T, Saller R.
    CMAJ; 1998 Oct 06; 159(7):759; author reply 759, 761. PubMed ID: 9805018
    [No Abstract] [Full Text] [Related]

  • 13. Clinical relevance of immunoactive mistletoe lectin-I.
    Beuth J.
    Anticancer Drugs; 1997 Apr 06; 8 Suppl 1():S53-5. PubMed ID: 9179369
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins.
    Büssing A, Schietzel M.
    Anticancer Res; 1999 Apr 06; 19(1A):23-8. PubMed ID: 10226520
    [Abstract] [Full Text] [Related]

  • 15. Viscotoxin-free aqueous extracts from European mistletoe (Viscum album L.) stimulate activity of human granulocytes.
    Stein GM, Pfüller U, Schietzel M.
    Anticancer Res; 1999 Apr 06; 19(4B):2925-8. PubMed ID: 10652574
    [Abstract] [Full Text] [Related]

  • 16. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
    Ribéreau-Gayon G, Jung ML, Frantz M, Anton R.
    Anticancer Drugs; 1997 Apr 06; 8 Suppl 1():S3-8. PubMed ID: 9179359
    [Abstract] [Full Text] [Related]

  • 17. [The mistletoe myth--claims, reality and provable perspectives].
    Gabius HJ, André S, Kaltner H, Siebert HC, von der Lieth CW, Gabius S.
    Z Arztl Fortbild (Jena); 1996 Apr 06; 90(2):103-10. PubMed ID: 8686332
    [Abstract] [Full Text] [Related]

  • 18. Immunoprotective activity of the galactoside-specific mistletoe lectin in cortisone-treated BALB/c-mice.
    Beuth J, Ko HL, Tunggal L, Buss G, Jeljaszewicz J, Steuer MK, Pulverer G.
    In Vivo; 1994 Apr 06; 8(6):989-92. PubMed ID: 7772751
    [Abstract] [Full Text] [Related]

  • 19. Polysaccharides from fresh Viscum album L. berry extract and their interaction with Viscum album agglutinin I.
    Edlund U, Hensel A, Fröse D, Pfüller U, Scheffler A.
    Arzneimittelforschung; 2000 Jul 06; 50(7):645-51. PubMed ID: 10965423
    [Abstract] [Full Text] [Related]

  • 20. Crystallization of the ribosome inactivating protein ML1 from Viscum album (mistletoe) complexed with beta-D-galactose.
    Sweeney EC, Palmer RA, Pfüller U.
    J Mol Biol; 1993 Dec 20; 234(4):1279-81. PubMed ID: 8263931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.